Tenet Healthcare Corp (NYSE: THC)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0000070318
Market Cap 18.07 Bn
P/B 4.50
P/E 13.34
P/S 0.87
ROIC (Qtr) 13.58
Div Yield % 0.00
Rev 1y % (Qtr) 3.18
Total Debt (Qtr) 13.19 Bn
Debt/Equity (Qtr) 3.29

About

Tenet Healthcare Corp, or THC, is a prominent player in the healthcare services industry. With its headquarters in Dallas, Texas, and a Global Business Center in Manila, Philippines, the company operates an extensive care delivery network that spans various administrative functions and subsidiaries. The company's main business activities include hospital operations, ambulatory care, and revenue cycle management, with a presence in several countries and regions. Tenet Healthcare Corp's Hospital Operations segment includes 61 acute care and specialty...

Read more

Price action

Investment thesis

Bull case

  • Healthy cash reserves of 2.98B provide 35x coverage of short-term debt 85M, demonstrating strong liquidity position and minimal refinancing risk.
  • Operating cash flow of 2.48B provides strong 26.36x coverage of stock compensation 94M, indicating sustainable incentive practices.
  • Robust free cash flow of 1.54B exceeds capital expenditure of 942M by 1.63x, indicating strong organic growth funding capability.
  • Robust tangible asset base of 16.91B provides 5.20x coverage of working capital 3.25B, indicating strong operational backing.
  • Tangible assets of 16.91B provide robust 5.42x coverage of other current liabilities 3.12B, indicating strong asset backing.

Bear case

  • Operating cash flow of 2.48B barely covers its investment activities of (1.26B), with a coverage ratio of -1.97, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Cash reserves of 2.98B provide limited coverage of acquisition spending of (313M), which is -9.50x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • High receivables of 2.52B relative to inventory of 346M (7.28 ratio) suggests aggressive credit terms or collection difficulties, potentially masking revenue quality issues.
  • Free cash flow of 1.54B represents just -5.57x of debt issuance (276M), suggesting concerning reliance on leverage rather than internal cash generation for growth.
  • Operating cash flow of 2.48B barely covers operating expenses of 9.06B with a 0.27 ratio, suggesting thin operational efficiency margins and limited flexibility.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.98 1.26
EV to Cash from Ops. EV/CFO 11.59 12.78
EV to Debt EV to Debt 2.18 12.10
EV to EBIT EV/EBIT 10.83 10.74
EV to EBITDA EV/EBITDA 7.10 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 18.69 18.02
EV to Market Cap EV to Market Cap 1.58 432.64
EV to Revenue EV/Rev 1.38 2.77
Price to Book Value [P/B] P/B 4.52 -1.92
Price to Earnings [P/E] P/E 13.41 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) 3.24 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -122.49 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -27.33 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -47.70 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -37.39 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) -48.40 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) -57.27 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) -53.10 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) -79.22 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -0.61 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.71 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.65 0.39
Current Ratio Curr Ratio (Qtr) 1.71 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 3.29 -13.19
Interest Cover Ratio Int Coverage (Qtr) 3.24 -97.94
Times Interest Earned Times Interest Earned (Qtr) 3.24 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 16.70 -95.81
EBIT Margin % EBIT Margin % (Qtr) 12.72 -94.97
EBT Margin % EBT Margin % (Qtr) 8.79 -105.60
Gross Margin % Gross Margin % (Qtr) 100.00 23.31
Net Profit Margin % Net Margin % (Qtr) 6.50 -106.14